LONDON--(BUSINESS WIRE)--DexCom, Inc. (Nasdaq: DXCM), a global leader in real-time continuous glucose monitoring (CGM) for people with diabetes, today announced both the launch of Dexcom ONE+, a CGM ...

Dexcom ONE+ is available today in Spain, Belgium, and Poland with the Netherlands launching next week, and additional countries to be announced in the coming months. New system continues to ensure ...

DexCom, Inc. DXCM announced that its DexCom ONE continuous glucose monitoring (CGM) system has been launched in France for people with diabetes. The latest CGM sensor from the company’s portfolio has ...

The Stelo glucose monitor. [Image courtesy of Dexcom] Dexcom (Nasdaq:DXCM) Chair, President and CEO Kevin Sayer says that, in 2019, he gave a speech announcing the company’s first $1 billion year.

The Stelo glucose monitor. [Image courtesy of Dexcom] Dexcom (Nasdaq:DXCM) announced that it submitted its new Stelo glucose sensor to the FDA for review at the end of last year. The continuous ...

DexCom. has filed a patent for a system involving a continuous analyte sensor with power-saving features. The system includes a sensor electronics module that can switch between measurement and low ...

GERMANTOWN, Md.--(BUSINESS WIRE)-- Senseonics Holdings, Inc. (NYSE American: SENS) a medical technology company focused on the development and commercialization of the first and only long-term, ...